ArticleJournal of translational medicine2023

Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.

Halvard Bonig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.